The conversation shouldnt be do we cover GLP-1s or not. It should be how do we cover them in a way thats clinically appropriate, financially sustainable, and competitive for talent. That reframe positions you as the strategic thinker, not the bearer of bad news
A., Singh, L., Singh, G
Lower bilirubin concentrations are also associated with systemic lupus erythematosus, Sjgrens syndrome, rheumatoid arthritis, polymyositis and antiphospholipid syndrome, in which reduced bilirubin concentrations are closely associated with inflammatory markers ( 71 - 75 )
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist
[18] In a study included in the Solnul research, consumption of resistant potato starch led to a noticeable increase in Akkermansia levels, improving gut health and promoting better digestion
Nuestra postura clnica: En Clivi no prescribimos estos frmacos a pacientes con antecedentes personales de pancreatitis crnica o aguda